The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preliminary result of a multicenter phase II study of chemoradiotherapy with docetaxel for elderly patients with stage II/III esophageal carcinoma.
Jun Hashimoto
No relevant relationships to disclose
Namiko Kotani
No relevant relationships to disclose
Nobukazu Hokamura
No relevant relationships to disclose
Yoshinori Ito
No relevant relationships to disclose
Chikatoshi Katada
No relevant relationships to disclose
Hiromichi Ishiyama
No relevant relationships to disclose
Yoshio Tamaki
No relevant relationships to disclose
Takayuki Nakamura
No relevant relationships to disclose
Ken Kato
No relevant relationships to disclose